Applications of RNA interference: current state and prospects for siRNA-based strategies in vivo
Author:
- 25 April 2007
- journal article
- review article
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 76 (1) , 9-21
Abstract
Within the recent years, RNA interference (RNAi) has become an almost-standard method for in vitro knockdown of any target gene of interest. Now, one major focus is to further explore its potential in vivo, including the development of novel therapeutic strategies. From the mechanism, it becomes clear that small interfering RNAs (siRNAs) play a pivotal role in triggering RNAi. Thus, the efficient delivery of target gene-specific siRNAs is one major challenge in the establishment of therapeutic RNAi. Numerous studies, based on different modes of administration and various siRNA formulations and/or modifications, have already accumulated promising results. This applies to various animal models covering viral infections, cancer and multiple other diseases. Continuing efforts will lead to the development of efficient and “double-specific” drugs, comprising of siRNAs with high target gene specificity and of nanoparticles enhancing siRNA delivery and target organ specificity.Keywords
This publication has 133 references indexed in Scilit:
- Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown miceNucleic Acids Research, 2006
- Melittin analogs with high lytic activity at endosomal pH enhance transfection with purified targeted PEI polyplexesJournal of Controlled Release, 2006
- In vivo delivery of small interfering RNA targeting brain capillary endothelial cellsBiochemical and Biophysical Research Communications, 2006
- EGF Receptor-Targeted Synthetic Double-Stranded RNA Eliminates Glioblastoma, Breast Cancer, and Adenocarcinoma Tumors in MicePLOS Medicine, 2005
- Cationic lipids enhance siRNA-mediated interferon response in miceBiochemical and Biophysical Research Communications, 2005
- Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activityProceedings of the National Academy of Sciences, 2004
- Argonaute2 Is the Catalytic Engine of Mammalian RNAiScience, 2004
- RNA Interference in Mammalian Cells by Chemically-Modified RNABiochemistry, 2003
- Induction of an interferon response by RNAi vectors in mammalian cellsNature Genetics, 2003
- Expression profiling reveals off-target gene regulation by RNAiNature Biotechnology, 2003